In the previously mentioned randomized study by Singhal, GM-CSF was associated with no deleterious effect on acute or chronic GvHD, relapse or survival after 5-year follow-up [8], while the study by Bishop also showed no difference between G-CSF and placebo in acute GvHD [4]. This evidence concerns the gene CSF3 and graft versus host disease.